Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Tip Treatment Paclitaxelifosfamidecisplatin

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (2)

Trial Status

Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Tip Treatment Paclitaxelifosfamidecisplatin1
  • Tumor Specimen Collection1
  • Questionnaire Administration1
  • Neoadjuvant Therapy1
  • Etoposide1

Active Sponsors

  • National Cancer Institute (NCI)1
  • Mayo Clinic1
  • Children's Oncology Group1
  • Yonsei University1

Top Investigators

Related Conditions

  • Mixed Germ Cell Tumor1
  • Embryonal Carcinoma1
  • Late Effects1
  • Germ Cell Tumor1
  • Choriocarcinoma1

Activity Timeline